Genuine Biosystem Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 8.36 M
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 26.85 Cr
- Satisfied Charges ₹ 1.00 Cr
- Revenue Growth -59.24%
- Profit Growth -82.70%
- Ebitda -76.26%
- Net Worth 8.54%
- Total Assets 3.91%
About Genuine Biosystem
Genuine Biosystem Private Limited (GBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 24 June 2013 and has a history of 11 years and seven months. Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.36 M.
The company currently has active open charges totaling ₹26.85 Cr. The company has closed loans amounting to ₹1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Dhanasekaran Muthusamy, Shyamala Dhanasekaran, Manju, and One other member serve as directors at the Company.
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24297TN2013PTC091808
- Company No.
091808
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jun 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
What products or services does Genuine Biosystem Private Limited offer?
Genuine Biosystem Private Limited offers a wide range of products and services, including Rapid Test Kit, Diagnostic Test Kit, Laboratory Reagents, Sweetener, Liquid Glucose, Clinical Reagents.
Who are the key members and board of directors at Genuine Biosystem?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shyamala Dhanasekaran  | Director | 24-Jun-2013 | Current |
| Dhanasekaran Muthusamy | Director | 24-Jun-2013 | Current |
| Manju | Director | 24-Jun-2013 | Current |
| Sudarsanraj Kumar | Director | 01-Oct-2014 | Current |
Financial Performance of Genuine Biosystem.
Genuine Biosystem Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 59.24% decrease. The company also saw a substantial fall in profitability, with a 82.7% decrease in profit. The company's net worth moved up by a moderate rise of 8.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genuine Biosystem?
In 2023, Genuine Biosystem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gmth Private LimitedShyamala Dhanasekaran is a mutual person
Charges (Loans)
₹26.85 Cr
₹1.00 Cr
Charges Breakdown by Lending Institutions
- Canara Bank : 25.90 Cr
- Others : 0.95 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Aug 2022 | Canara Bank | ₹25.90 Cr | Open |
| 27 Aug 2018 | Others | ₹1.04 M | Open |
| 27 Aug 2018 | Others | ₹8.46 M | Open |
| 06 Nov 2014 | Hdfc Bank Limited | ₹1.00 Cr | Satisfied |
How Many Employees Work at Genuine Biosystem?
Genuine Biosystem has a workforce of 63 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genuine Biosystem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genuine Biosystem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.